TScan Therapeutics, Inc. - COM (TCRX)

Historical Portfolio Holders from Q3 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
41.4M
Holdings value Q2 2024
$242M
Value change Q2 2024
+$40.5M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
78
Number of buys Q2 2024
48
Number of sells Q2 2024
-29
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 15.6K $78K +$78K $5.01 1
2024 Q2 41.4M $242M +$40.5M $5.85 78
2024 Q1 34.3M $272M +$19.1M $7.94 65
2023 Q4 31.9M $186M +$7.21M $5.83 53
2023 Q3 28.6M $73.2M +$2.18M $2.56 31
2023 Q2 27.9M $69.9M +$45.8M $2.50 27
2023 Q1 9.66M $20.3M +$589K $2.10 27
2022 Q4 9.52M $14.8M -$121K $1.55 28
2022 Q3 9.51M $29M -$531K $3.05 24
2022 Q2 9.68M $30.4M +$1.53M $3.14 23
2022 Q1 9.41M $26.3M -$1.5M $2.80 24
2021 Q4 9.86M $44.4M -$2.46M $4.50 28
2021 Q3 9.5M $78.2M +$78.2M $8.34 25